VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, today announced the expansion of its ...
Our data and the mechanism of Up-frameshift 1 (hUPF1) action suggest that the efficacy of this therapy would be agnostic to patients’ genetic background. To improve AAV packaging and thus convey ...
Viral vector service expansion empowers scientists by offering high-quality research reagents through on-demand AAV production from Addgene’s vast plasmid repository Addgene, a purpose-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results